Potential Role of Oral Thiazolidinedione Therapy in Preserving ??-Cell Function in Type 2 Diabetes Mellitus
- 1 January 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 65 (1), 1-13
- https://doi.org/10.2165/00003495-200565010-00001
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Coefficient of failure: a methodology for examining longitudinal β‐cell function in Type 2 diabetesDiabetic Medicine, 2002
- Clinical evidence of thiazolidinedione‐induced improvement of pancreatic β‐cell function in patients with type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2002
- Effect of Pioglitazone on Blood Proinsulin Levels in Patients with Type 2 Diabetes Mellitus.Endocrine Journal, 2002
- The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAnnals of Internal Medicine, 2001
- Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.Diabetes Care, 2000
- Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.JCI Insight, 1997
- Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.JCI Insight, 1994
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- β-Cell Dysfunction Induced by Chronic Hyperglycemia: Current Ideas on Mechanism of Impaired Glucose-Induced Insulin SecretionDiabetes Care, 1992
- Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.JCI Insight, 1983